March 28th 2025
Fitusiran (Qfitlia) is approved for patients 12 years and older with or without factor VIII or IX inhibitors.
Four-dollar pricing considered boon and bust
August 11th 2008Are $4 generics the future of pharmacy? Perhaps so, as the consumption of generic drugs soars and their costs drop. Wal-Mart, which beat a thorny path to what many pharmacists believe is loss-leader pricing, says $4 was a great move. It is very popular-and good for business.
Added to platinum-based chemotherapy, cetuximab improves lung cancer survival
August 11th 2008Of more than 4,000 cancer studies presented at the recent annual meeting of the American Society of Clinical Oncology, those exploring effects of targeted therapy cetuximab combined with platinum-based chemotherapy generated the most buzz.